Perbedaan Indofarma Tbk. dan Niramas Utama Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Niramas Utama Tbk. diperdagangkan di Rp515 (kapitalisasi pasar 670,98 M, volume 24 jam 3,31 jt). Perbedaan utamanya: Niramas Utama Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | JELI | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 670,98 M |
Volume | — | 3,31 jt |
Lot | — | 33,07 rb |
Perputaran | — | 1,71 M |
Harga Rata-rata | — | 516,6 |
Nilai Transaksi | — | 1,71 M |
Harga Ekuilibrium Indikatif | — | 515 |
Volume Ekuilibrium Indikatif | — | 680 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Selengkapnya di halaman JELI →